Patents by Inventor Matthew J. Hart

Matthew J. Hart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10295417
    Abstract: A load cell for measuring load in a rod, the load cell is described. The load cell is formed by a cylindrical strain member having a cylindrical aperture there through. The cylindrical aperture sized to fit the rod. The strain member includes a plurality of slots that create contact points there between for strain member to contact the rod in a predicable manner. A plurality of strain gages located adjacent to the contact points, the strain gages producing an electrical voltage proportional to the load on the rod.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: May 21, 2019
    Assignee: Group Four Transducers, Inc.
    Inventors: Matthew J. Hart, Robert L. Gray
  • Publication number: 20150075296
    Abstract: A load cell for measuring load in a rod, the load cell is described. The load cell is formed by a cylindrical strain member having a cylindrical aperture there through. The cylindrical aperture sized to fit the rod. The strain member includes a plurality of slots that create contact points there between for strain member to contact the rod in a predicable manner. A plurality of strain gages located adjacent to the contact points, the strain gages producing an electrical voltage proportional to the load on the rod.
    Type: Application
    Filed: September 18, 2014
    Publication date: March 19, 2015
    Applicant: GROUP FOUR TRANSDUCERS INC
    Inventors: Matthew J. Hart, Robert L. Gray
  • Patent number: 7994294
    Abstract: The present invention relates to all aspects of a guanine exchange factor (GEF), for example, a Rho-GEF, such as p115 Rho-GEF. A GEF modulates cell signaling pathways, both in in vitro and in vivo, by modulating the activity of a GTPase. By way of illustration, a p115 Rho-GEF, which modulates the activity of a Rho GTPase, is described. However, the present invention relates to other GEFs, especially other Rho-GEFs. The present invention particularly relates to an isolated p115 Rho-GEF polypeptide or fragments of it, a nucleic acid coding for p115 Rho-GEF or fragments of it, and derivatives of the polypeptide and nucleic acid. The invention also relates to methods of using such polypeptides, nucleic acids, or derivatives thereof, e.g., in therapeutics, diagnostics, and as research tools.
    Type: Grant
    Filed: November 22, 2006
    Date of Patent: August 9, 2011
    Assignee: Onyx Pharmaceuticals, Inc.
    Inventor: Matthew J. Hart
  • Patent number: 7148002
    Abstract: The present invention relates to all aspects of a guanine exchange factor (GEF), for example, a Rho-GEF, such as p115 Rho-GEF. A GEF modulates cell signaling pathways, both in in vitro and in vivo, by modulating the activity of a GTPase. By way of illustration, a p115 Rho-GEF, which modulates the activity of a Rho GTPase, is described. However, the present invention relates to other GEFs, especially other Rho-GEFs. The present invention particularly relates to an isolated p115 Rho-GEF polypeptide or fragments of it, a nucleic acid coding for p115 Rho-GEF or fragments of it, and derivatives of the polypeptide and nucleic acid. The invention also relates to methods of using such polypeptides, nucleic acids, or derivatives thereof, e.g., in therapeutics, diagnostics, and as research tools.
    Type: Grant
    Filed: May 27, 2003
    Date of Patent: December 12, 2006
    Assignee: Onyx Pharmaceuticals, Inc.
    Inventor: Matthew J. Hart
  • Publication number: 20040048288
    Abstract: The present invention relates to all aspects of a guanine exchange factor (GEF), for example, a Rho-GEF, such as p115 Rho-GEF. A GEF modulates cell signaling pathways, both in in vitro and in vivo, by modulating the activity of a GTPase. By way of illustration, a p115 Rho-GEF, which modulates the activity of a Rho GTPase, is described. However, the present invention relates to other GEFs, especially other Rho-GEFs. The present invention particularly relates to an isolated p115 Rho-GEF polypeptide or fragments of it, a nucleic acid coding for p115 Rho-GEF or fragments of it, and derivatives of the polypeptide and nucleic acid. The invention also relates to methods of using such polypeptides, nucleic acids, or derivatives thereof, e.g., in therapeutics, diagnostics, and as research tools.
    Type: Application
    Filed: May 27, 2003
    Publication date: March 11, 2004
    Inventor: Matthew J. Hart
  • Patent number: 6569655
    Abstract: The present invention relates to all aspects of a guanine exchange factor (GEF), for example, a Rho-GEF, such as p115 Rho-GEF. A GEF modulates cell signaling pathways, both in in vitro and in vivo, by modulating the activity of a GTPase. By way of illustration, a p115 Rho-GEF, which modulates the activity of a Rho GTPase, is described. However, the present invention relates to other GEFs, especially other Rho-GEFs. The present invention particularly relates to an isolated p115 Rho-GEF polypeptide or fragments of it, a nucleic acid coding for p115 Rho-GEF or fragments of it, and derivatives of the polypeptide and nucleic acid. The invention also relates to methods of using such polypeptides, nucleic acids, or derivatives thereof, e.g., in therapeutics, diagnostics, and as research tools.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: May 27, 2003
    Assignee: Onyx Pharmaceuticals, Inc.
    Inventor: Matthew J. Hart
  • Publication number: 20020192785
    Abstract: The present invention relates to all aspects of a guanine exchange factor (GEF), for example, a Rho-GEF, such as p115 Rho-GEF. A GEF modulates cell signaling pathways, both in in vitro and in vivo, by modulating the activity of a GTPase. By way of illustration, a p115 Rho-GEF, which modulates the activity of a Rho GTPase, is described. However, the present invention relates to other GEFs, especially other Rho-GEFs. The present invention particularly relates to an isolated p115 Rho-GEF polypeptide or fragments of it, a nucleic acid coding for p115 Rho-GEF or fragments of it, and derivatives of the polypeptide and nucleic acid. The invention also relates to methods of using such polypeptides, nucleic acids, or derivatives thereof, e.g., in therapeutics, diagnostics, and as research tools.
    Type: Application
    Filed: May 25, 2001
    Publication date: December 19, 2002
    Inventor: Matthew J. Hart
  • Patent number: 6238881
    Abstract: The present invention relates to all aspects of a guanine exchange factor (GEF), for example, a Rho-GEF, such as p115 Rho-GEF. A GEF modulates cell signaling pathways, both in in vitro and in vivo, by modulating the activity of a GTPase. By way of illustration, a p115 Rho-GEF, which modulates the activity of a Rho GTPase, is described. However, the present invention relates to other GEFs, especially other Rho-GEFs. The present invention particularly relates to an isolated p115 Rho-GEF polypeptide or fragments of it, a nucleic acid coding for p115 Rho-GEF or fragments of it, and derivatives of the polypeptide and nucleic acid. The invention also relates to methods of using such polypeptides, nucleic acids, or derivatives thereof, e.g., in therapeutics, diagnostics, and as research tools.
    Type: Grant
    Filed: October 6, 1997
    Date of Patent: May 29, 2001
    Assignee: Onyx Pharmaceuticals, Inc.
    Inventor: Matthew J. Hart